★ Metabolic Longevity

Epithalon

Metabolic Longevity · 10mg × 10 vials

In plain terms: Epithalon is a research compound - injectable, fast-acting and well studied.

✓ 98%+ Purity ✓ Lab Tested ✓ COA on Request ✓ Discreet Shipping ✓ Direct Support
📋 Certificate of Analysis Request the third-party COA via Telegram
Quick Start
🧪
Format
Injectable (reconstituted) · 10mg × 10 vials
🎯
Who it's for
longevity goals
💉
How it's run
5 mg subcutaneous, once daily, in the evening
When you'll notice
sleep/circadian improvements within the 10-day pulse; telomere/longevity effects are cumulative across multi-year pulse cycling
Pricing
$105from · kit of 10
In US stock · 2-5 day UPS 2nd Day Air
+ $40 ship · singles $20 · free over $1k per tier
10mg × 10 vials$105
50mg × 10 vials$260
Order / Consult on Telegram →
short (peptide cleared within minutes to hours; downstream effects on telomerase and pineal expression persist for months)
Half-life
pulse (10-20 days on / 4-6 months off)
Cycling
sleep/circadian improvements within the 10-day pulse
First effects
metabolic-longevity
Class
Overview

What Is Epithalon?

Epithalon (Ala-Glu-Asp-Gly, also called Epitalon or AEDG) is a synthetic tetrapeptide modeled on Epithalamin, the polypeptide extract of the bovine pineal gland that Vladimir Khavinson's St. Petersburg Institute of Bioregulation and Gerontology spent decades studying starting in the 1970s. The headline mechanism is telomerase activation: in cultured human somatic cells, Epithalon induces transcription of the TERT gene (the catalytic subunit of telomerase), restores telomerase activity in cells that normally have it switched off, and extends telomere length by 33% in some passage studies, which lets fibroblasts complete additional Hayflick-limit divisions they otherwise would not. Beyond the telomere story, Epithalon acts as a bioregulator of the pineal axis: it restores age-related decline in pineal melatonin secretion, normalizes the diurnal cortisol rhythm, and modulates expression of clock genes (Per1, Per2, BMAL1, CLOCK) in peripheral tissues. Animal studies show it raises antioxidant defense (glutathione, SOD), reduces lipid peroxidation, and shifts the hypothalamic gonadotropin axis toward a younger pattern. In plain customer language: it is the "telomere/sleep peptide", it pulses the pineal gland back into a more youthful pattern, and the effects persist long after the 10-day course because gene expression and telomere length carry forward.

Protocols

Typical dose ranges by experience level - educational reference. Message us and we tailor it to you.

Protocol5 mg subcutaneous, once daily, in the evening
Frequency1× per day for 10 consecutive days
Duration10-day pulse, then 4-6 months completely off before next pulse

This is the Khavinson "minimum effective protocol" and the most common community starting point. Most first-time users run two 10-day pulses per year (every 6 months). Sleep improvement is the most consistently reported subjective signal during the pulse, often noticeable by day 3-5. One ET10 kit (10 vials × 10 mg) covers one beginner pulse at 5 mg/day for 20 days, or two 10-day pulses if split tightly. The 10 mg vial size makes 5 mg dosing a half-vial proposition, so plan reconstitution accordingly.

Protocol10 mg subcutaneous, once daily, in the evening
Frequency1× per day for 10-20 consecutive days
Duration10-20 day pulse, then 4-6 months off

10 mg/day for 10 days is the dose used in most published Khavinson cohort studies. Some intermediate users extend to 20 consecutive days once or twice per year (the original "geroprotector course"). One ET10 kit covers one 10-day pulse at 10 mg/day exactly. Customers serious about telomere/longevity work usually move to this dose after running one or two beginner pulses. The 5 mg/ml reconstitution gives a clean 2.0 ml dose per day (can be split into two 1.0 ml injections in different sites if 2 ml in one site is too much volume).

Protocol10 mg subcutaneous, once daily for 20 consecutive days, OR 10 mg twice daily for 10 days (morning + evening, ~20 mg total/day)
Frequency1-2× per day depending on protocol
Duration20-day pulse, 2× per year (every 6 months), or extended 30-day protocols documented in some clinics

20-day continuous courses are documented in the older Russian protocols (Khavinson + Anisimov used 20-day intramuscular courses in elderly cohorts). The 10 mg BID protocol (~20 mg/day) is community-driven, not from Khavinson originals, and pulled from peptide forums where users wanted to compress a full course into 10 days. The ET50 kit (50 mg × 10 vials = 500 mg total) is the right buy at this level: one ET50 vial reconstituted to 5 ml at 10 mg/ml gives 5 daily doses of 10 mg from a single vial, so the full kit covers ~50 days of pulse work, enough for 2-5 advanced cycles. Advanced users almost universally pair Epithalon pulses with continuous HGH or CJC+Ipa work between pulses - the "stack the deck" anti-aging combo.

What To Expect
sleep/circadian improvements within the 10-day pulse
noticeable change
telomere/longevity effects are cumulative across multi-year pulse cycling
noticeable change
Side Effects

Straight talk - what people actually report, and what the studies measured.

What users report
From forums, Discord & TikTok
  • Vivid dreams: most-reported subjective effect, often noticed by day 2-3 of the pulse. Users describe more cinematic, narrative-rich dreams. Tied to the pineal/melatonin reset.
  • Improved sleep depth and morning energy: very consistent across r/Peptides, peptide forums, and longevity Twitter. Many users report falling asleep faster and waking more refreshed during the 10-day pulse, with the effect persisting weeks-to-months after.
  • Mild euphoria or mood lift: reported by a subset of users, attributed to the serotonin/melatonin pathway influence
  • Reduced anxiety / calmer baseline: secondary signal, less universal than the sleep effect
  • Headache: occasional, usually mild and self-limiting in the first 1-3 days of a pulse, attributed to melatonin pathway shift
  • Skin/hair quality improvements: anecdotal, slower-build signal across multi-pulse users (1-2 years of biannual pulsing)
  • No clinically meaningful adverse effects in the community either. Epithalon has one of the cleanest tolerability profiles in the longevity peptide space.
  • - Divergence: Clinical trials report nothing notable; community reports a strong sleep/dreams signal that the Russian literature mentions but does not emphasize as a primary endpoint. This is a case of community detecting a subjective benefit that the trials measured as a secondary outcome.
What the studies show
Measured in clinical trials
  • Russian/Khavinson trials report essentially no significant adverse events at protocol doses. The published cohort studies in elderly patients (60-87 years) running 5-10 mg/day for 10-20 days noted no clinically meaningful side effects across multi-year follow-ups.
  • Injection site reactions: mild redness or transient soreness at the injection site, the most common physical observation, resolves within hours
  • No documented changes in liver enzymes, kidney markers, or hematological parameters across the published Russian cohorts
  • No clinically observed hypotension, allergic reactions, or systemic adverse events at standard dosing
  • Western RCT data is essentially absent - the Khavinson literature is the substantive evidence base, and methodological standards differ from FDA-style trials
The Research

Peer-reviewed studies and clinical guidelines - tap any to read the source.

PubMedKhavinson VK, Bondarev IE, Butyugov AA - Epithalon peptide induces telomerase activity and telomere elongation in human somatic cells, Bull Exp Biol Med 2003

foundational telomerase activation paper in human fibroblasts

Read study ↗
PubMedKhavinson VK, Morozov VG - Peptides of pineal gland and thymus prolong human life, Neuro Endocrinol Lett 2003

12-year follow-up cohort, Epithalon + Thymalin combined, 1.6-1.8× mortality reduction in elderly

Read study ↗
PubMedAnisimov VN, Khavinson VK - Peptide bioregulation of aging: results and prospects, Biogerontology 2010

comprehensive review of the Khavinson peptide bioregulator program including Epithalon

Read study ↗
PubMedKhavinson VK - Peptides and Ageing, Neuro Endocrinol Lett 2002, vol 23 suppl 3

review of pineal peptide longevity work and the original Epithalamin → Epithalon synthesis story

Read study ↗
PubMedKorkushko OV, Khavinson VK et al - Geroprotective effects of Epithalamin in elderly patients, Bull Exp Biol Med 2007

clinical cohort showing restored melatonin secretion and circadian rhythm normalization

Read study ↗
PubMedAnisimov VN, Khavinson VK et al - Effect of Epitalon on biomarkers of aging, life span and spontaneous tumor incidence in female SHR mice, Mech Ageing Dev 2003

animal lifespan extension data, addresses the tumor question (no increased tumor incidence at protocol doses)

Read study ↗
+ 3 more studies & references
From The Community

Aggregated sentiment from public forums & socials - real-world reports, not individual endorsements.

Rr/Peptides Epithalon

Vivid dreams: most-reported subjective effect, often noticed by day 2-3 of the pulse. Users describe more cinematic, narrative-rich dreams. Tied to the pineal/melatonin reset.

Rr/longevity Epithalon

Improved sleep depth and morning energy: very consistent across r/Peptides, peptide forums, and longevity Twitter. Many users report falling asleep faster and waking more refreshed during the 10-day pulse, with the effect persisting weeks-to-months after.

PPeptide

Mild euphoria or mood lift: reported by a subset of users, attributed to the serotonin/melatonin pathway influence

TTom Bilyeu / TikTok lo

Reduced anxiety / calmer baseline: secondary signal, less universal than the sleep effect

Rr/Peptides Epithalon

Headache: occasional, usually mild and self-limiting in the first 1-3 days of a pulse, attributed to melatonin pathway shift

Rr/longevity Epithalon

Skin/hair quality improvements: anecdotal, slower-build signal across multi-pulse users (1-2 years of biannual pulsing)

Common Questions
SubQ injection (most common in research and community use). Intranasal and IM are documented in some Khavinson protocols; subQ is the PP default..
sleep/circadian improvements within the 10-day pulse; telomere/longevity effects are cumulative across multi-year pulse cycling
A popular pairing is Epithalon + HGH (Somatropin). See the Protocols section, or ask us for a stack built around your goal.
Yes. Every batch is third-party lab tested - request the COA on Telegram and we send it over.
Safety & Contraindications

Hard stops

  • Active malignancy or recent cancer history - telomerase activation in tumor cells is a theoretical concern. Most published studies were in elderly populations without active cancer; the cancer-promotion question has not been settled in humans, and the prudent default is to avoid Epithalon in anyone with active or recent-history malignancy.
  • Pregnancy or breastfeeding - no safety data, blanket avoid
  • Children / adolescents - no safety data, no rationale for use

Caution flags

  • Family history of cancers strongly associated with telomerase reactivation (e.g., certain leukemias, some carcinomas) - discuss with a knowledgeable physician
  • Severe pineal pathology or pineal cyst - theoretical, no data
  • Existing strong melatonin supplementation - Epithalon shifts endogenous melatonin secretion; stacking with exogenous melatonin is fine but the customer may not need both

Stacking conflicts

  • No documented pharmacological conflicts with the standard peptide stack (reta, BPC, TB-500, GHK-Cu, NAD+, HGH, CJC+Ipa, MOTS-c, sema/tirz). Epithalon's targets (telomerase, pineal gene expression) don't overlap with anything else in the catalog.
  • Stacking with other pineal-axis compounds (Pinealon, DSIP, melatonin) is biologically additive, not conflicting, but the cumulative sleep effect can be strong; titrate the stack, not Epithalon itself.
Is It Right For You?

✓ Good fit

  • longevity goals
  • anti-aging stacks
  • sleep quality issues
  • post-50 customers
  • HGH users wanting to "stack the deck"
  • customers running biannual cycles
  • telomere-focused researchers

✗ Not a fit

  • active cancer
  • recent cancer history
  • pregnancy
  • weight-loss-only goals
  • customers wanting daily continuous-use compounds
  • first-time peptide buyers with no clear longevity plan

Administration & Storage

Route: SubQ injection (most common in research and community use). Intranasal and IM are documented in some Khavinson protocols; subQ is the PP default.

Injection site: abdomen or outer thigh, rotate sites

Storage: refrigerated, ~28 days. Lyophilized vials store room temp short-term, refrigerate or freeze for longer-term hold. Light sensitivity is low compared to BPC/TB but standard practice is amber-glass or fridge storage out of direct light.

Notes: Evening injection is preferred since the pineal/melatonin axis is the primary target. Most users dose 30-60 min before bed so the peptide is in circulation during the natural melatonin onset window. The peptide is cleared quickly so timing matters more than for long-half-life compounds like reta. Don't shake the vial; swirl gently to dissolve.

All products sold for research purposes only. Not for human or animal consumption. Must be 21 or older to purchase. By placing an order you confirm compliance with all applicable local laws and regulations.